Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

The test can pick up several types of cancer, including pancreatic and ovarian, years before symptoms appear.

Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.

By removing a single gene, researchers change the developmental fate of tumor cells in mice.  

The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

Scientists produce a detailed genomic map of mutations and epigenetic changes associated with smoking tobacco across 17 tumor types. 

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

Researchers and regulators reflect on the progress that has been made in preventing tobacco-related disease in the 50 years since the publication of the first U.S. Surgeon General’s report. 

March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.